CasLoc logo
All Cases PTAB Litigations UPC Oppositions

DR. FALK PHARMA GMBH vs. Ellodi Pharmaceuticals LP

Explore the PTAB proceeding IPR2024-01197 filed by DR. FALK PHARMA GMBH on 2024-07-22. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2024-01197

Filing Date

2024-07-22

Accorded Filing Date

2024-07-22

Institution Decision Date

2025-01-27

Last Modified Date

2026-01-13

Proceeding Type

IPR

Termination Date

2025-10-27

Trial Status

Terminated-Adverse Judgment

Parties & Counsel

Petitioner

Patent Owner / Respondent

Patent Information

1 Patent Involved
Respondent Application Number 12896005
Respondent Patent Number 8771729
Legal Expiration Date
2030-12-30 Active (4.1 yrs remaining)
Patent Term Adjustment (PTA) +90 Days Awarded
Injunction Viability (35 U.S.C. § 283) Active Threat
Respondent Inventor Stephen Perrett et al
Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Decisions Rendered

2 Total

Proceeding Status

Terminated-Adverse Judgment

Administrative Patent Judges (APJ Panel)

Panel assignment tracked upon institution decision entry

Board Decisions & Rulings (2)

Request For Adverse Judgment After Institution 2025-10-27
JUDGMENT Granting Motion to Terminate and Request for Adverse Judgment after Institution of Trial 37 C.F.R. § 42.73(b)
37 CFR 42.73
Institution Granted 2025-01-27
Institution Decision: Grant
37 CFR 42.100, 37 CFR 42.108, 35 USC 314, 37 CFR 42.104

Address and Attorney/Agent Information

31 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name Cooley LLP / Eurand
Customer Number 91543
Address ATTN: Patent Group, 1299 Pennsylvania Avenue, Suite 700, Washington, DC, 20004, UNITED STATES

Attorney / Agent Information

Reg # Name Phone
32289 Frank Pietrantonio +1 703-456-8567
33885 William Galliani +1 650-843-5622
34262 C Talbot +1 703-456-8072
36977 Kevin Zimmer +1 858-945-8634
41087 Christopher Hutter +1 703-456-8506
42887 Erik Milch +1 202-416-5845
43210 Michael Tuscan +1 202-842-7802
43255 Bonnie Mcleod +1 202-842-7800

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 11 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials 4 proceedings
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (11): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (4 found):
PTAB: 4
USPTO PTAB Trial 2025-09-19
PGR2025-00086

Dr. Falk Pharma GmbH v. Ellodi Pharmaceuticals

U.S. Continuation Sibling (12290598)
Status: Terminated-Adverse Judgment
USPTO PTAB Trial 2024-10-24
IPR2025-00052

Dr. Falk Pharma GmbH v. Ellodi Pharmaceuticals LP

U.S. Continuation Sibling (10632069)
Status: Terminated-Adverse Judgment
USPTO PTAB Trial 2024-10-24
IPR2025-00055

Dr. Falk Pharma GmbH v. Ellodi Pharmaceuticals LP

U.S. Continuation Sibling (9486407)
Status: Terminated-Adverse Judgment
USPTO PTAB Trial 2024-10-24
IPR2025-00054

Dr. Falk Pharma GMBH v. Ellodi Pharmaceuticals LP

U.S. Continuation Sibling (11246828)
Status: Terminated-Adverse Judgment
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Proceeding Documents

132
41

JUDGMENT Granting Motion to Terminate and Request for Adverse Judgment after Institution of Trial 37 C.F.R. § 42.73(b) ADVRSJUDG

2025-10-27 FILING PARTY: BOARD
3007

Email from Petitioner re non-opposition to Patent Owner’s Motion requesting Acceptance Exhibit

2025-10-27 FILING PARTY: BOARD
40

ORDER Granting Patent Owner’s Motion Requesting Acceptance of Submission of Patent Owner’s Request for Adverse Judgment and Motion to Terminate Filed under Board’s Alternative Means 37 C.F.R. § 42.6(b)(2)(i) ORDER

2025-10-27 FILING PARTY: BOARD
3006

Email from Patent Owner re Request for Authorization to File Motion to Terminate etc. Exhibit

2025-10-27 FILING PARTY: BOARD
2026

Disclaimer for US Patent No. 8,771,729 Exhibit

2025-10-24 FILING PARTY: PATENT OWNER

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc